Table 3. The number and proportion of prescriptions with inappropriate splitting, by physician specialty.
| Total | Metabolism | Cardiology | Gen Med | Neurology | Psychiatry | Nephrology | Surgery | Others | ||||||||||
| n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | n | (%) | |
| All drug items | 1238 | (1.0) | 429 | (3.4) | 297 | (1.3) | 149 | (1.2) | 88 | (0.8) | 86 | (1.5) | 81 | (1.3) | 47 | (0.6) | 61 | (0.1) |
| Anti-diabetic Agents | 623 | (5.8) | 347 | (6.6) | 111 | (5.8) | 81 | (4.9) | 10 | (1.8) | 0 | 37 | (13.2) | 7 | (2.8) | 30 | (3.6) | |
| Gliclazide MR tab30 mg (Diamicron®) | 549 | (6.7) | 292 | (7.2) | 109 | (6.7) | 74 | (6.4) | 3 | (0.9) | 0 | 36 | (14.4) | 7 | (4.7) | 28 | (4.7) | |
| Metformin ER tab500 mg (Ansures®) | 74 | (2.9) | 55 | (4.8) | 2 | (0.7) | 7 | (1.4) | 7 | (2.9) | 0 | 1 | (3.3) | 0 | 2 | (0.9) | ||
| Cardiovascular Drugs | 372 | (0.7) | 71 | (1.1) | 127 | (0.7) | 63 | (1.0) | 42 | (1.0) | 2 | (0.5) | 31 | (0.9) | 27 | (1.4) | 9 | (0.1) |
| Fluvastatin XL tab80 mg (Lescol®) | 224 | (5.3) | 45 | (5.4) | 81 | (5.5) | 50 | (6.1) | 16 | (3.4) | 0 | 17 | (7.5) | 15 | (10.0) | 0 | ||
| Felodipine ER tab5 mg (Plendil®) | 48 | (0.4) | 11 | (0.7) | 10 | (0.2) | 5 | (0.2) | 11 | (0.7) | 2 | (0.9) | 3 | (0.3) | 6 | (1.1) | 0 | |
| Doxazosin XL tab4 mg (Doxaben®) | 27 | (0.4) | 8 | (1.4) | 9 | (0.3) | 3 | (0.7) | 3 | (1.2) | 0 | 2 | (0.3) | 0 | 2 | (0.1) | ||
| Diltiazem retard tab90 mg (Cardizem®) | 26 | (0.7) | 4 | (1.0) | 8 | (0.3) | 3 | (1.9) | 0 | 0 | 0 | 6 | (4.8) | 5 | (4.4) | |||
| Nifedipine OROS tab30 mg (Adalat®) | 18 | (0.2) | 0 | 6 | (0.1) | 0 | 0 | 6 | (0.7) | 0 | 6 | (0.6) | 0 | 0 | ||||
| Others | 29 | (0.2) | 3 | (0.3) | 13 | (0.4) | 2 | (0.1) | 6 | (0.6) | 0 | 3 | (0.6) | 0 | 2 | (0.0) | ||
| Central NervousSystem Agents | 210 | (0.9) | 4 | (4.0) | 56 | (11.4) | 5 | (1.0) | 36 | (0.8) | 76 | (1.7) | 4 | (10.3) | 13 | (0.4) | 16 | (0.2) |
| Alprazolam XR tab0.5 mg (Xanax®) | 117 | (6.5) | 4 | (5.3) | 56 | (13.4) | 0 | 30 | (8.0) | 4 | (2.2) | 0 | 13 | (9.9) | 10 | (2.0) | ||
| Bupropion XL tab150 mg (Wellbutrin®) | 59 | (3.6) | 0 | 0 | 5 | (11.1) | 1 | (1.3) | 46 | (3.2) | 4 | (80.0) | 0 | 3 | (14.3) | |||
| Valproate EC tab200 mg (Depakine®) | 18 | (0.9) | 0 | 0 | 0 | 2 | (0.3) | 13 | (1.1) | 0 | 0 | 3 | (1.6) | |||||
| Others | 16 | (0.0) | 0 | 0 | 0 | 3 | (0.0) | 13 | (0.8) | 0 | 0 | 0 | ||||||
| Gastrointestinal Drugs | 15 | (0.1) | 4 | (0.7) | 3 | (0.3) | 0 | 0 | 8 | (1.0) | 0 | 0 | 0 | |||||
| Others | 18 | (0.1) | 3 | (0.9) | 0 | 0 | 0 | 0 | 9 | (0.9) | 0 | 2 | ||||||
Prescriptions for adult (age >18 yrs).
Metabolism, Metabolism & endocrinology; Gen Med, General medicine; n, number of prescriptions with inappropriate splitting.
%, n/N, proportion of prescriptions with inappropriate splitting by specific drug and physician specialty (N: number of prescriptions with special oral formulation by the specific drug and physician specialty in Table S1.).